Department of Radiation Oncology, 1500 E. Medical Center Drive, UH B2C490 SPC 5010, Ann Arbor, MI 48109, USA.
Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e93-9. doi: 10.1016/j.ijrobp.2010.12.067. Epub 2011 May 17.
Assess dosimetric correlates of long-term dysphagia after chemo-intensity-modulated radiotherapy (IMRT) of oropharyngeal cancer (OPC) sparing parts of the swallowing organs.
Prospective longitudinal study: weekly chemotherapy concurrent with IMRT for Stages III/IV OPC, aiming to reduce dysphagia by sparing noninvolved parts of swallowing-related organs: pharyngeal constrictors (PC), glottic and supraglottic larynx (GSL), and esophagus, as well as oral cavity and major salivary glands. Dysphagia outcomes included patient-reported Swallowing and Eating Domain scores, Observer-based (CTCAEv.2) dysphagia, and videofluoroscopy (VF), before and periodically after therapy through 2 years. Relationships between dosimetric factors and worsening (from baseline) of dysphagia through 2 years were assessed by linear mixed-effects model.
Seventy-three patients participated. Observer-based dysphagia was not modeled because at >6 months there were only four Grade ≥2 cases (one of whom was feeding-tube dependent). PC, GSL, and esophagus mean doses, as well as their partial volume doses (V(D)s), were each significantly correlated with all dysphagia outcomes. However, the V(D)s for each organ intercorrelated and also highly correlated with the mean doses, leaving only mean doses significant. Mean doses to each of the parts of the PCs (superior, middle, and inferior) were also significantly correlated with all dysphagia measures, with superior PCs demonstrating highest correlations. For VF-based strictures, most significant predictor was esophageal mean doses (48±17 Gy in patients with, vs 27±12 in patients without strictures, p = 0.004). Normal tissue complication probabilities (NTCPs) increased moderately with mean doses without any threshold. For increased VF-based aspirations or worsened VF summary scores, toxic doses (TDs)(50) and TD(25) were 63 Gy and 56 Gy for PC, and 56 Gy and 39 Gy for GSL, respectively. For both PC and GSL, patient-reported swallowing TDs were substantially higher than VF-based TDs.
Swallowing organs mean doses correlated significantly with long-term worsening of swallowing. Different methods assessing dysphagia resulted in different NTCPs, and none demonstrated a threshold.
评估头颈部癌症调强放疗(IMRT)中避免吞咽器官部分照射后长期吞咽困难的剂量学相关性。
前瞻性纵向研究:每周进行化疗,同时进行 IMRT,适用于 III/IV 期口咽癌,旨在通过避免非受累吞咽相关器官的部分照射来减少吞咽困难:咽缩肌(PC)、声门和喉上部(GSL)以及食管,以及口腔和主要唾液腺。在治疗后 2 年内通过定期治疗前和治疗后评估吞咽困难的患者报告的吞咽和进食域评分、基于观察者(CTCAEv.2)的吞咽困难和视频荧光镜检查(VF)。通过线性混合效应模型评估剂量学因素与 2 年内吞咽困难恶化(与基线相比)之间的关系。
73 名患者参与了研究。由于在>6 个月时只有 4 例(其中 1 例依赖饲管)为 2 级以上,因此未对观察者评估的吞咽困难进行建模。PC、GSL 和食管的平均剂量以及它们的部分体积剂量(V(D)s)与所有吞咽困难结果均显著相关。然而,每个器官的 V(D)s 相互关联,并且与平均剂量高度相关,仅保留平均剂量具有统计学意义。PC 各部分(上、中、下)的平均剂量也与所有吞咽障碍指标显著相关,其中上 PC 相关性最高。对于基于 VF 的狭窄,最显著的预测因子是食管的平均剂量(有狭窄的患者为 48±17 Gy,无狭窄的患者为 27±12 Gy,p=0.004)。没有任何阈值,正常组织并发症概率(NTCP)随着平均剂量的增加而适度增加。对于基于 VF 的吸入增加或 VF 综合评分恶化,PC 的毒性剂量(TD)(50)和 TD(25)分别为 63 Gy 和 56 Gy,GSL 分别为 56 Gy 和 39 Gy。对于 PC 和 GSL,患者报告的吞咽 TD 明显高于基于 VF 的 TD。
吞咽器官的平均剂量与长期吞咽功能恶化显著相关。不同的评估吞咽困难的方法导致不同的 NTCP,且均未显示出阈值。